节点文献
胰高血糖素样肽-1及其类似物治疗2型糖尿病的优势
Superiority of GLP-1 and Its Analogues in Treating Type 2 Diabetes Mellitus
【摘要】 胰高血糖素样肽-1是肠道L细胞分泌的一种十分重要的肠促胰岛素,其主要生理作用包括进食后刺激胰岛素的分泌和释放,抑制胰高血糖素的分泌,促进β细胞的增殖并抑制其凋亡,抑制胃排空,促进饱食感的产生等。胰高血糖素样肽-1类似物同样具有上述作用。但与其他降血糖药物相比,胰高血糖素样肽-1及其类似物在β细胞保护及降低体重方面具有独特优势。因此,胰高血糖素样肽-1类似物作为新型的治疗2型糖尿病药物,可改变糖尿病的自然进程。
【Abstract】 GLP-1 is an important incm in secreted by intestinal L cells,of which the main physiological effects are stimulating the secretion and releasing of insulin after eating,inhibiting the secretion of hyporglycosemia,promoting the proliferation of β-cell in pancreas while inhibiting its apoptosis,inhibiting gastric evacuation,improving the feeling of overeating and so on.GLP-1 analogues have the same effect above.However,compared with other hypoglycemic drugs,GLP-1 and its analogues in the β cell protection,and weight-loss have a unique advantage.Therefore,GLP-1 analogues which is a new treatment of type 2 diabetes drugs,can change the natural process of diabetes.
【Key words】 glucagon-like peptide-1; protection of the β-cell; weight-loss;
- 【文献出处】 循证医学 ,The Journal of Evidence-Based Medicine , 编辑部邮箱 ,2010年06期
- 【分类号】R587.105
- 【被引频次】7
- 【下载频次】320